New York, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a USA based, proprietary developer of a patented advanced laser enrichment technology, announced that Jeffrey L. Binder, Ph.D., MBA, has been appointed to serve as a Technical Nuclear Advisor for the Company, with a primary emphasis on laboratory support.
Author or co-author of over 100 publications, articles, and conference submittals, Jeffrey L. Binder obtained a Ph.D. in nuclear engineering from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago. Dr. Binder’s career in applied energy technology has spanned over 30 years as both an engineering & scientific contributor. His experiences include nuclear reactor technology, renewable energy, advanced/critical materials, and manufacturing technology.
“I am delighted to join the esteemed team at LIS Technologies,” said Jeffrey L. Binder, Ph.D., Technical Nuclear Advisor to LIS Technologies Inc. “My belief has long been that the innovative integration of physics and chemistry is crucial for realizing the vast possibilities within the nuclear energy sector. The quality and promise I see within this company are truly remarkable and I am eager to contribute my expertise to this crucial domestic and global endeavor.”
Dr. Binder has significant international experience in promoting nuclear and renewable energy technology. He has had multiple leadership roles including Associate Laboratory Director for applied energy at Oak Ridge and Argonne National Laboratories and Founding Director of the University of Illinois Applied Research Institute.
“It is a pleasure to welcome Dr. Binder to his role as Technical Nuclear Advisor,” said Christo Liebenberg, Co-Founder and Chief Executive Officer of LIS Technologies Inc. “Dr. Binders’ storied career cements his standing as a pivotal advocate for the advancement of nuclear energy in the United States. His extensive and well-established connections with the United States National Laboratories infrastructure, we believe will help facilitate more efficient navigation through the regulatory landscape and create opportunities for additional collaborations with government offices.”
About LIS Technologies Inc.
LIS Technologies Inc. (LIST) is a USA based, proprietary developer of a patented advanced laser technology, making use of infrared wavelengths to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including uranium enrichment, and several major advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. The LIST proprietary laser-based process is more energy-efficient and has the potential to be deployed with highly competitive capital and operational costs. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR), the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies. The Company employs a world class nuclear technical team working alongside leading nuclear entrepreneurs and industry professionals, possessing strong relationships with government and private nuclear industries.
For more information please visit: LaserIsTech.com
For further information, please contact:
Email: info@laseristech.com
Telephone: 800-388-5492
Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "will", "should", "could", "would" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control. For LIS Technologies Inc., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by any worsening of global business and economic environment: (i) risks related to the development of new or advanced technology, including difficulties with design and testing, cost overruns, development of competitive technology, loss of key individuals and uncertainty of success of patent filing, (ii) our ability to obtain contracts and funding to be able to continue operations and (iii) risks related to uncertainty regarding our ability to commercially deploy a competitive laser enrichment technology, (iv) risks related to the impact of government regulation and policies including by the DOE and the U.S. Nuclear Regulatory Commission; and other risks and uncertainties discussed in this and our other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Attachment
